Highlights from the HFSA Annual Scientific Meeting 2023
On this episode, we bring you interviews recorded live at the HFSA Annual Scientific Meeting in early October 2023. The episode kicks off with a discussion with HFSA President James C. Fang, MD, FHFSA, followed by chats with three Late Breaking Clinical Trial presenters (Marat Fudim, MD, MHS; Marvin Konstam, MD; and James L. Januzzi, MD, FACC, FESC); and finally, a highlight reel with HFSA Social Media Catalysts Anju Bhardwaj, MD and Shashank S. Sinha, MD, MSc.
Michael Beasley, MD, Assistant Professor of Medicine at the Yale School of Medicine @MHBeasleyMD
Priya Umapathi, MD, Assistant Professor in the Division of Cardiology & Advanced Heart Failure and Heart Transplant Cardiologist at Johns Hopkins Hospital @priyaumapathi
Chapters and Guests:
00:00:01 James C. Fang, MD, FHFSA, HFSA President, Professor of Medicine, Chief, Division of Cardiovascular Medicine, Executive Director, Cardiovascular Service Line at University of Utah, Salt Lake City, UT
00:07:09 Marat Fudim, MD, MHS - REBALANCE-HF, Heart Failure Cardiologist at Duke University Medical Center
00:12:10 Marvin Konstam, MD - ANTHEM-HFrEF, Chief Physician Executive, The CardioVascular Center, Professor at Tufts University School of Medicine
00:17:55 James L. Januzzi, MD, FACC, FESC - TRACER-HF, Hutter Family Professor of Medicine, HMS, Director of Heart Failure and Biomarker Trials, Baim Institute at Massachusetts General Hospital @JJheart_doc
00:25:20 Anju Bhardwaj, MD, Assistant Professor/Faculty at McGovern Medical School at University of Texas in Houston @docbhardwaj & Shashank S. Sinha, MD, MSc, Medical Director/Cardiologist at Inova Fairfax Hospital @ShashankSinhaMD
- Fudim M. Endovascular ablation of the right greater splanchnic nerve in HFpEF: primary analysis of the REBALANCE-HF randomized trial. Presented at: HFSA 2023. October 8, 2023. Cleveland, OH.
Konstam MA. ANTHEM HF-rEF pivotal study: primary and supplemental endpoint results. Presented at: HFSA 2023. October 8, 2023. Cleveland, OH.
Januzzi, J. Effect Of Trientine-hydrochloride In Heart Failure With Lower Left Ventricular Ejection Fraction: The TRACER-HF Trial. Presented at: HFSA 2023. October 9, 2023. Cleveland, OH.
Marat Fudim consults/has equity in AxonTherapies
James Januzzi research support from Innolife, Inc